Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 63

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 % infections lung HSCT women RVI GVHD expression BAL preterm donor pneumocystis NEC oct4 IA
2 patients viral lung transplantation stem pregnancy respiratory engraftment cancer CMV birth donors pneumonia infants corneal agvhd
3 = infection rejection deficiency pregnant tract TBI eif3f bronchoalveolar inflammation kidney pancreatic surgery cancer response
4 median immune pulmonary immunodeficiency maternal virus alemtuzumab CXCL14 allo‐hsct AF heart pneumocystis pneumonia visits removal htrs
5 CI infectious bronchiolitis cell pregnant women CARV + GC lavage preterm birth mice biopsy pandemic cells ioaes
6 95 transplant dysfunction SCID delivery RSV EBV colorectal fluid MR transplantation R-CHOP ACDMPV esophageal stent
7 study mortality allograft hematopoietic stem cell transplantation placental HCT gvhd FGL2 infiltrates PCR/ESI-MS organ PCP abnormal esophageal cancer HLH
8 incidence viruses obliterans autologous fetal syncytial ATG adenocarcinoma pulmonary intra-amniotic skin PJP ER port micafungin
9 days viral infections lung transplant recurrent cesarean LRTD t-cell carcinoma pulmonary infiltrates births alloantibody FCR transfusion prostate fenestrated
10 METHODS risk acute severe SARS respiratory syncytial virus irradiation cancers PCR score donation lymphoma enterocolitis TIVAP second-line
11 rate solid BOS patient placentas IPS dogs BCRP RVP‐PCR amniotic kidney transplant jirovecii prematurity pluripotency branched
12 disease morbidity CLAD marrow COVID-19 influenza relapse LC-CD133(+ bronchoalveolar lavage mr score CD26(–/– non-hodgkin 's radiation antifungal
13 RESULTS fungal acute rejection bone ZIKV LRTI gy lung adenocarcinoma DNA gestational metagenomic non-hodgkin lymphoma necrotizing PDIS caspofungin
14 6 pathogens syndrome allogeneic mother respiratory tract infection body tumor testing PROM organ transplantation PCNSL atypical port infection etanercept
15 occurred bacterial bronchiolitis obliterans syndrome report fetus upper i.v cervical LOSP intra-amniotic inflammation liver CAP united embryonic partial
16 analysis organ chronic genetic intrauterine parainfluenza total body irradiation PRSS copies/ml SPB transplanted surgical CM CTC ECP
17 underwent strategies noninfectious successful published RV serotherapy lung cancer pneumonia prevalence cytokines cohort healthcare prostate cancer mold infections
18 months recipients transplantation stem cell perinatal allo-lss haploidentical genotype diagnostic preterm prom sensitized biopsies decitabine water mold
19 BACKGROUND opportunistic idiopathic includes labor lower controls SSTR2 microbiologic preterm infants ascs pancreatic biopsy CHD corneal perforation scans
20 retrospective population important mutations covid-19 pneumonia IFD low-dose cetuximab yield frequency jcpyv hematological cancer necrotizing enterocolitis ipscs PAP
21 12 common AMR indications trimester PIV cmv disease POP load chorioamnionitis cytokine absolute nno preferred antifungal therapy
22 1 respiratory viruses CBO failure preterm delivery carvs subq marker specimens RNA transmission count older radiation oncologist responders
23 compared immunocompromised early combined congenital hdct/auto-sct ptcy levels bronchoscopy mass recipient AIDS AML oncologist 72
24 < prevention LB preventing ribavirin RBV days carriers NP amniotic fluid screening NHL full-term perforation P<0.01
25 CONCLUSIONS treatment mechanisms guidelines delivered ratio immunosuppression cervical cancer VL gestational age current immunocompromise united states somatic treatment
26 7 viral infection idiopathic pneumonia syndrome hematopoietic observed models chimerism TNBC FB weeks extensive ASCT ectopic bipscs asymptomatic
27 CONCLUSION complications chronic lung allograft dysfunction IKBKB distress knowledge donor oct-4 predictive BPD reduced 2-year states maintaining therapy
28 100 regimens recipients immune deficiency elective odds ratio dose adjacent diagnosis CS donor screening aplastic infection‐related embryonic stem cells CT
29 30 bacteria injury working respiratory distress syndrome allo-ls cyclosporine DFS AHSCT cultivation CD26(+/+ lung biopsy assessments rivers HR
30 significant including major CID hcs respiratory virus TTV her‐2/neu bronchial preterm births CD26 2007 non-htx HCV immunosuppressive drugs
31 versus transplantation exosomes thrombocytopenia vaginal vris CD3 resistance positive early-onset non-sensitized HCT neonatal item aortic
32 associated with therapy lung allograft ICF vertical transmission 60-day depleted migration washing samples spleen users neonates pluripotent voriconazole
33 vs. factors lung injury ois newborns adenovirus doses breast iu/ml tests mpbls authorized miscarriage lakes haplo‐sct
34 2 life increasingly ADA vertical transplant graft-versus-host correlated rvp‐pcr testing spontaneous anti-donor online version added tarsorrhaphy allo-ric
35 results patients bronchiolitis obliterans comorbidities transmission infection grafts recurrence cmv pneumonia plasma samples kidney transplantation version EPAC 0.0001 nonresponders
36 allogeneic solid organ transplant histopathologic blood neonatal detection dla-identical prognosis diagnostic yield bronchopulmonary dysplasia donations supplementary formula framework cgvhd
37 survival suppression complications diseases mode coronavirus viremia EVT 100‐day microbial-associated secreting 89.6 avoidance mscs half
38 interval affecting development delay exposed .01 CR negatively survival rate perinatal mortality UCB cosavirus gram‐negative regraft grafting
39 OS cell BO MIRAGE third trimester metapneumovirus weeks colorectal carcinoma AGA proteomic antigen‐specific online CD applied first-line therapy
40 24 donor-derived costimulatory stem cell transplantation 2019 ISI graft MGT SCT ionization igg prevalences feeding scs intraoperative
41 28 infectious complications alloimmune engrafted severe all-cause marrow polymorphisms cut-off sterile serum cats emergency M1 ct scans
42 clinical drug organizing curative therapy syndrome year received breast cancer BALF burden graft rejection SUPPLEMENTARY post-epac self-renewal efficacy
43 odds disease forced homozygous placenta human metapneumovirus infusion-related CD133 allogeneic hematopoietic stem cell transplant adverse pregnancy collected SCNSL reassessments mesenchymal phase
44 difference stem LTR syndrome malformations upper respiratory tract infection tacrolimus plays qrt-pcr perinatal rejection receiving postoperative calibrated GVHD
45 enrolled community-acquired DSA clinical cesarean delivery predictor mycophenolate AURKA performed age transplant cases hemorrhage HM 15
46 31 broad clinical presentation cells hiv-1-infected allo‐hsct recipients renal transplant epitopes pulmonary infiltrate infants graft PD low tumor non-responders
47 complications donor-derived infections ltx cases unborn recipients dlis cancer surgery dna loads MIAC alloab .008 7.4 adult aneurysms
48 adjusted immune suppression molecule post-hsct congenital malformations children dog cells deleterious STB disease transmission postmortem incurred conclusion 2/13
49 TRM hematopoietic expiratory starting nonelective associated with conditioned significantly polymerase chain reaction ge/well complexity pancreatitis deferred white blood cell combination
50 cell epidemiology supportive * intrauterine growth restriction hematopoietic mg/kg normal dna load electrospray ionization mass spectrometry musculoskeletal pathogen(s ciliary embryonic-like screening